L
Lotfi Aleya
Researcher at Centre national de la recherche scientifique
Publications - 362
Citations - 7402
Lotfi Aleya is an academic researcher from Centre national de la recherche scientifique. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 36, co-authored 307 publications receiving 4986 citations. Previous affiliations of Lotfi Aleya include Blaise Pascal University & University of Burgundy.
Papers
More filters
Journal ArticleDOI
Identification of Ascorbic Acid and Gallic Acid as Novel Inhibitors of Secreted Frizzled-Related Protein for the Treatment of Obesity-Induced Type 2 Diabetes
Shazia Anwer Bukhari,Aysha Yasmin,Azhar Rasul,Muhammad Kashif Zahoor,Ghulam Mustafa,Dunia A. Al Farraj,N. M. Darwish,Lotfi Aleya,Asim Rehman +8 more
TL;DR: The results of this study suggest that ascorbic acid and gallic acid have potential for the treatment of obesity-induced T2D.
Journal ArticleDOI
Effects of Zinc Substitution on the Microstructural and Magnetic Characteristics of Cubic Symmetry Nickel Ferrite System
TL;DR: In this article , the preparation of ZnxNi1−xFe2O4 (x = 0 and 0.3) nanoparticles using glycine-mediated combustion route was successfully completed depending on the zwitterion and combustion characteristics of glycine.
Journal ArticleDOI
Lycopene attenuates chlorpyrifos-induced hepatotoxicity in rats via activation of Nrf2/HO-1 axis.
Ashraf B. Abdel-Naim,Emad H.M. Hassanein,Lenah S. Binmahfouz,Amina M. Bagher,Rawan H. Hareeri,Mardi M. Algandaby,Yousef Abdal Jalil Fadladdin,Lotfi Aleya,Mohamed M. Abdel-Daim +8 more
TL;DR: In this article , the potential hepatoprotective actions of Lycopene against chlorpyrifos (CPF) induced hepatotoxicity in rats were evaluated. And the observed protective effects of LCP were further confirmed by a significant enhancement in heme oxygenase-1 (HO-1) and NF-E2-related factor 2 (Nrf2) expression.
Journal ArticleDOI
Emergence of nutriments as a nascent complementary therapy against antimicrobial resistance
Rajwinder Kaur,Muskan Kanotra,Ankita Sood,Ahmed A. H. Abdellatif,Saurabh Bhatia,Ahmed Al-Harrasi,Lotfi Aleya,Celia Vargas-De-la-Cruz,Tapan Behl +8 more
TL;DR: Antimicrobial adjuvants that aim towards non-essential bacterial targets to reduce the prevalence of resistant bacterial infections, latest bioinformatics approach towards antibacterial drug discovery along with an understanding of biogenic nanoparticles in antimicrobial activity are discussed.